| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |